Bioservo Technologies AB Interim Report January – September 2023
July-September in figures · Net sales of 4.2 MSEK (1.9) · EBITDA of -9.3 MSEK (-9.9) · EBIT of -9.8 MSEK (-10.7) · Earnings for the period amounted to -9.8 MSEK (-10.7) · Earnings per share before and after dilution amounted to SEK -0.12 (-0.56) · Cash flow from operating activities for the period amounted to – 15.2 MSEK (-15.0) January-September in figures · Net sales of 10.0 MSEK (8.4) · EBITDA of -29.6 MSEK (-31.6) · EBIT of -31.0 MSEK (-34.6) · Earnings for the period amounted to -31.1 MSEK (-34.6) · Earnings per share before and after dilution